APA (7th ed.) Citation

SP, R., NS, K., R, S., D, S., H, Z., K, P., . . . A, Z. (2019). Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 14(4), 608. https://doi.org/10.1007/s11481-019-09849-y

Chicago Style (17th ed.) Citation

SP, Raikwar, et al. "Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 14, no. 4 (2019): 608. https://doi.org/10.1007/s11481-019-09849-y.

MLA (9th ed.) Citation

SP, Raikwar, et al. "Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, vol. 14, no. 4, 2019, p. 608, https://doi.org/10.1007/s11481-019-09849-y.